Jangra, Sonia
Landers, Jeffrey J.
Laghlali, Gabriel
Rathnasinghe, Raveen
Warang, Prajakta
Park, Seok-Chan
O’Konek, Jessica. J. http://orcid.org/0000-0002-1455-0586
Singh, Gagandeep http://orcid.org/0000-0003-3260-2631
Janczak, Katarzyna W.
García-Sastre, Adolfo http://orcid.org/0000-0002-6551-1827
Arya, Nandini
Karadag, Dilara
Baker, James R. Jr.
Schotsaert, Michael http://orcid.org/0000-0003-3156-3132
Wong, Pamela T. http://orcid.org/0000-0002-4387-4723
Article History
Received: 8 January 2023
Accepted: 9 June 2023
First Online: 29 June 2023
Competing interests
: P.W., M.S., J.R.B., and A.G.S. are co-inventors on a patent for NE-IVT. M.S. received research support from Phio Pharmaceuticals, Moderna and Argen-X. The A.G.-S. laboratory has received research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck, outside of the reported work. A.G.-S. has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, Paratus, CureLab Oncology, CureLab Veterinary, Synairgen and Pfizer, outside of the reported work. A.G.-S. has been an invited speaker in meeting events organized by Seqirus, Janssen, Abbott and Astrazeneca. A.G.-S. is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York. The remaining authors declare that the research was conducted in the absence of any competing interests.